ATE528009T1 - Reepithelialisierende pharmazeutische zusammensetzungen, die xanthangummi enthalten - Google Patents
Reepithelialisierende pharmazeutische zusammensetzungen, die xanthangummi enthaltenInfo
- Publication number
- ATE528009T1 ATE528009T1 AT07108593T AT07108593T ATE528009T1 AT E528009 T1 ATE528009 T1 AT E528009T1 AT 07108593 T AT07108593 T AT 07108593T AT 07108593 T AT07108593 T AT 07108593T AT E528009 T1 ATE528009 T1 AT E528009T1
- Authority
- AT
- Austria
- Prior art keywords
- gum
- xanthang
- reepithelializing
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/723—Xanthans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02425274A EP1358883B8 (de) | 2002-04-30 | 2002-04-30 | Xanthangummi enthaltende reepithelialisierende pharmazeutische Zubereitungen |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE528009T1 true ATE528009T1 (de) | 2011-10-15 |
Family
ID=28799773
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02425274T ATE367165T1 (de) | 2002-04-30 | 2002-04-30 | Xanthangummi enthaltende reepithelialisierende pharmazeutische zubereitungen |
AT07108593T ATE528009T1 (de) | 2002-04-30 | 2002-04-30 | Reepithelialisierende pharmazeutische zusammensetzungen, die xanthangummi enthalten |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02425274T ATE367165T1 (de) | 2002-04-30 | 2002-04-30 | Xanthangummi enthaltende reepithelialisierende pharmazeutische zubereitungen |
Country Status (15)
Country | Link |
---|---|
US (5) | US8912164B2 (de) |
EP (2) | EP1913948B1 (de) |
JP (2) | JP4837912B2 (de) |
CN (1) | CN100502884C (de) |
AT (2) | ATE367165T1 (de) |
AU (1) | AU2003230224B2 (de) |
BR (1) | BR0304655A (de) |
CA (2) | CA2749172C (de) |
DE (2) | DE60221227T2 (de) |
DK (1) | DK1358883T3 (de) |
ES (2) | ES2290264T3 (de) |
MX (1) | MXPA04010668A (de) |
PT (1) | PT1358883E (de) |
RU (1) | RU2297230C2 (de) |
WO (1) | WO2003092706A1 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE367165T1 (de) * | 2002-04-30 | 2007-08-15 | Sifi Spa | Xanthangummi enthaltende reepithelialisierende pharmazeutische zubereitungen |
EP1507543A4 (de) | 2002-05-09 | 2006-07-26 | Cambridgemed Inc | Pharmazeutische zusammensetzung zur behandlung von wunden mit blutplasma oder serum |
WO2006035969A1 (ja) * | 2004-09-28 | 2006-04-06 | Senju Pharmaceutical Co., Ltd. | キサンタンガムおよびアミノ酸を含有する眼科用組成物 |
ITRM20050443A1 (it) * | 2005-08-12 | 2007-02-13 | Opocrin Spa | Preparati oftalmici a base di polisaccaridi mucoadesivi con capacita' riepitelizzante della cornea. |
KR101381035B1 (ko) | 2006-03-23 | 2014-04-04 | 센주 세이야꾸 가부시키가이샤 | 잔탄검 및 글루코스를 포함하는 안약 조성물 |
US20110117189A1 (en) * | 2008-07-08 | 2011-05-19 | S.I.F.I. Societa' Industria Farmaceutica Italiana S.P.A. | Ophthalmic compositions for treating pathologies of the posterior segment of the eye |
JP5620168B2 (ja) * | 2010-06-30 | 2014-11-05 | Dsp五協フード&ケミカル株式会社 | キシログルカン−カチオン複合体及びそれを含有する安定化組成物 |
IT1404145B1 (it) * | 2010-12-27 | 2013-11-15 | Altergon Sa | Composizioni di acido ialuronico stabilizzate verso l'azione di degradazione del calore o degli enzimi |
ES2751248T3 (es) * | 2011-11-24 | 2020-03-30 | Toyo Sugar Refining Co Ltd | Agente protector queratoconjuntival o agente inhibidor de trastornos queratoconjuntivales |
KR102588589B1 (ko) * | 2015-05-18 | 2023-10-16 | 히데미 카키하라 | 항균 물질 및 액상 항균제 및 액상 항균제의 제조 방법 |
BR112018013082A2 (pt) | 2015-12-29 | 2018-12-11 | Intervet Int Bv | vacina contra coccidiose |
CN106236704A (zh) * | 2016-08-30 | 2016-12-21 | 上海昊海生物科技股份有限公司 | 一种兼具仿生和靶向功能的莫西沙星滴眼液及其制备方法 |
CN114245737A (zh) | 2019-06-11 | 2022-03-25 | 司斐股份有限公司 | 微乳剂组合物 |
IT202000002296A1 (it) * | 2020-02-06 | 2021-08-06 | Sifi Spa | Formulazioni topiche oftalmiche a base di xantano con ridotta posologia |
MX2021003369A (es) * | 2021-03-22 | 2022-09-23 | Laboratorios Grin S A De C V | Lágrima ocular triple. |
IT202200000821A1 (it) * | 2022-01-19 | 2023-07-19 | Sifi Spa | Formulazioni topiche oftalmiche a base di xantano con ridotta posologia |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4136177A (en) * | 1977-01-31 | 1979-01-23 | American Home Products Corp. | Xanthan gum therapeutic compositions |
US4370324A (en) | 1980-09-17 | 1983-01-25 | Bernstein Joel E | Method and composition for treating and preventing irritation of the eyes |
US4525346A (en) | 1981-09-28 | 1985-06-25 | Alcon Laboratories, Inc. | Aqueous antimicrobial ophthalmic solutions |
US4711780A (en) * | 1984-06-11 | 1987-12-08 | Fahim Mostafa S | Composition and process for promoting epithelial regeneration |
US4826872A (en) | 1986-12-03 | 1989-05-02 | Takeda Chemical Industries, Ltd. | Pharmaceutical composition for treatment of cataract |
JPH0723317B2 (ja) * | 1988-03-17 | 1995-03-15 | 生化学工業株式会社 | 角膜上皮層障害症治療剤 |
JPH0651638B2 (ja) * | 1989-02-13 | 1994-07-06 | 新技術事業団 | 角膜上皮創傷治療用点眼剤 |
US5271943A (en) * | 1989-10-27 | 1993-12-21 | Scott Health Care | Wound gel compositions containing sodium chloride and method of using them |
IT1243435B (it) * | 1990-10-05 | 1994-06-10 | Altergon Sa | Composizioni farmaceutiche per uso topico comprendenti acido ialuronico sale sodico e sostanze disinfettanti |
US5804213A (en) * | 1991-10-09 | 1998-09-08 | Lectec Corporation | Biologically active aqueous gel wound dressing |
US6277365B1 (en) * | 1997-09-18 | 2001-08-21 | Bausch & Lomb Incorporated | Ophthalmic composition including a cationic glycoside and an anionic therapeutic agent |
DE20022450U1 (de) * | 1999-01-19 | 2002-01-17 | Mann Gerhard Chem Pharm Fab | Künstliche Tränenflüssigkeit in Gelform |
JP2004506688A (ja) * | 2000-08-23 | 2004-03-04 | フェアーソン・メディカル・インコーポレーテッド | 損傷、および他の適応症の治療 |
AU2002232437A1 (en) * | 2000-12-20 | 2002-07-01 | Alcon Universal Ltd. | Ophthalmic lubricating solution adapted for use in lasik surgery |
ATE367165T1 (de) * | 2002-04-30 | 2007-08-15 | Sifi Spa | Xanthangummi enthaltende reepithelialisierende pharmazeutische zubereitungen |
-
2002
- 2002-04-30 AT AT02425274T patent/ATE367165T1/de active
- 2002-04-30 PT PT02425274T patent/PT1358883E/pt unknown
- 2002-04-30 ES ES02425274T patent/ES2290264T3/es not_active Expired - Lifetime
- 2002-04-30 DE DE60221227T patent/DE60221227T2/de not_active Expired - Lifetime
- 2002-04-30 AT AT07108593T patent/ATE528009T1/de not_active IP Right Cessation
- 2002-04-30 DE DE07108593T patent/DE07108593T1/de active Pending
- 2002-04-30 EP EP07108593A patent/EP1913948B1/de not_active Expired - Lifetime
- 2002-04-30 DK DK02425274T patent/DK1358883T3/da active
- 2002-04-30 ES ES07108593T patent/ES2304913T3/es not_active Expired - Lifetime
- 2002-04-30 EP EP02425274A patent/EP1358883B8/de not_active Expired - Lifetime
-
2003
- 2003-04-24 JP JP2004500890A patent/JP4837912B2/ja not_active Expired - Lifetime
- 2003-04-24 CN CNB038095068A patent/CN100502884C/zh not_active Expired - Lifetime
- 2003-04-24 AU AU2003230224A patent/AU2003230224B2/en not_active Expired
- 2003-04-24 BR BR0304655-9A patent/BR0304655A/pt not_active Application Discontinuation
- 2003-04-24 CA CA2749172A patent/CA2749172C/en not_active Expired - Lifetime
- 2003-04-24 WO PCT/IT2003/000257 patent/WO2003092706A1/en active Application Filing
- 2003-04-24 CA CA2484020A patent/CA2484020C/en not_active Expired - Lifetime
- 2003-04-24 MX MXPA04010668A patent/MXPA04010668A/es active IP Right Grant
- 2003-04-24 US US10/512,521 patent/US8912164B2/en active Active
- 2003-04-24 RU RU2004131550/15A patent/RU2297230C2/ru active
-
2008
- 2008-02-14 US US12/031,518 patent/US20080146530A1/en not_active Abandoned
- 2008-02-14 US US12/031,495 patent/US20080139522A1/en not_active Abandoned
- 2008-02-14 US US12/031,483 patent/US20080139502A1/en not_active Abandoned
-
2011
- 2011-01-14 JP JP2011005761A patent/JP5203472B2/ja not_active Expired - Lifetime
-
2016
- 2016-02-25 US US15/054,090 patent/US20160166601A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE528009T1 (de) | Reepithelialisierende pharmazeutische zusammensetzungen, die xanthangummi enthalten | |
ATE464880T1 (de) | Arzneistoffnanopartikel mit lysozym- oberflächenstabilisator | |
RS51764B (en) | TRANSDERMAL PHARMACEUTICAL COMPOSITION | |
EP2070509A3 (de) | Die Verwendung von Myrica gale Öl | |
IS7820A (is) | Samsetningar sem innihalda melatónín, musterisviðog bíótín | |
BRPI0508579A (pt) | composto, composição farmacêutica, e, uso de um composto | |
ATE179884T1 (de) | Viskoelastische zusammensetzungen aus organischen fluorierten verbindungen | |
DE60329994D1 (de) | Selbstbräuner enthaltend wasserlösliche Vitamin B3-Komponente und Bräunungswirkstoff mit Alpha-Hydroxycarbonyl-Gruppierung | |
WO2004078105A3 (fr) | Composition de fondaparinux sodique de haute purete | |
NO20041509L (no) | Rengjoringspreparat. | |
AR057648A1 (es) | Composicion de metaflumizona para la administracion topica | |
ATE315395T1 (de) | Pharmazeutische zusammensetzungen, die faropenem natrium und eine diamineacetat verbindung zur verbesserung der magen-darm trakt absorption enthalten | |
DE60232271D1 (de) | Wässrige pharmazeutische formulierungen von wasserlöslichen prodrugs von propofol-verbindungen | |
CA2529441A1 (en) | Use of hyaluronic acid for preparing compositions for treating oral cavity aphthas | |
ATE464043T1 (de) | Pharmazeutische zusammensetzung enthaltend l- arginin | |
ATE412404T1 (de) | Stabile orale pharmazeutische zusammensetzungen von buprenorphin und salz davon | |
ATE359350T1 (de) | Verdickte wässrige zusammensetzungen | |
SE0000303D0 (sv) | Novel compounds | |
BRPI0412453A (pt) | uso do ácido ascórbico ou um sal fisiologicamente aceitável do mesmo | |
MXPA04005033A (es) | Composicion farmaceutica que comprende una combinacion de metformina y acido 4-oxobutanoico y el uso de la misma para el tratamiento contra diabetes. | |
EA200701525A1 (ru) | Фармацевтическая полимерная композиция для перорального введения тербуталина сульфата с контролируемым высвобождением | |
ATE301469T1 (de) | Pharmazeutische diclofenac-verbindung basierend auf vitamin e, papain und hyaluronidase | |
ATE307102T1 (de) | 3,3-dimethylcyclohexan-derivate | |
UY27376A1 (es) | Formulación de medicamento que contiene un antagonista de ltb4 | |
HRPK20040924B3 (en) | Preparation based on curcumae longae rhizomae roots |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |